Literature DB >> 10762303

Gastrointestinal mucormycosis complicated by arterio-enteric fistula in a patient with non-Hodgkin's lymphoma.

N Mir1, R Edmonson, T Yeghen, H Rashid.   

Abstract

Gastrointestinal mucormycosis is a rare, often fatal, systemic infection found predominantly in immunocompromised patients. We report a case of gastrointestinal mucormycosis in a 53-year-old female with non-Hodgkin's lymphoma. Following her first course of chemotherapy, bowel obstruction developed as a result of mucormycosis. Despite treatment with antifungal therapy, she required a laparotomy owing to severe haemorrhage caused by mucormycosal invasion of her iliac artery. With continued antifungal treatment and further chemotherapy, she ultimately underwent reversal of her Hartmann's procedure and remains disease-free.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10762303     DOI: 10.1046/j.1365-2257.2000.00264.x

Source DB:  PubMed          Journal:  Clin Lab Haematol        ISSN: 0141-9854


  5 in total

1.  Gastrointestinal mucormycosis initially manifest as hematochezia from arterio-enteric fistula.

Authors:  Jordan M Cloyd; Janice Brown; Tiffany Sinclair; David Jenks; Jay Desai; Teri Longacre; Venita Chandra; Andy Shelton
Journal:  Dig Dis Sci       Date:  2014-12       Impact factor: 3.199

2.  Arterio-enteric Fistula - An Unusual Complication of Improper Wound Closure.

Authors:  Atul Gupta; G L Tiwari
Journal:  Med J Armed Forces India       Date:  2011-07-21

Review 3.  Ileocolonic mucormycosis in adult immunocompromised patients: a surgeon's perspective.

Authors:  Oswens Siu-Hung Lo; Wai-Lun Law
Journal:  World J Gastroenterol       Date:  2010-03-07       Impact factor: 5.742

4.  Volcano-like intermittent bleeding activity for seven years from an arterio-enteric fistula on a kidney graft site after pancreas-kidney transplantation: a case report.

Authors:  Peter Härle; Stephan Schwarz; Julia Langgartner; Jürgen Schölmerich; Gerhard Rogler
Journal:  J Med Case Rep       Date:  2010-11-08

5.  Sargramostim (rhu GM-CSF) as Cancer Therapy (Systematic Review) and An Immunomodulator. A Drug Before Its Time?

Authors:  Hillard M Lazarus; Carolyn E Ragsdale; Robert Peter Gale; Gary H Lyman
Journal:  Front Immunol       Date:  2021-08-17       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.